Publications by authors named "C Campen"

: While the diagnosis of postural orthostatic tachycardia syndrome (POTS) is based on heart rate (HR) and blood pressure (BP) criteria, the pathophysiology of POTS is not fully understood as multiple pathophysiological mechanisms have been recognized. Also, cardiac function, being dependent on preload, afterload, contractility, and HR, has not been properly studied. Preload and contractility changes can be inferred from stroke volume index (SVI) changes during a tilt test.

View Article and Find Full Text PDF

Introduction: Orthostatic intolerance is highly prevalent in patients with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and is caused by an abnormal reduction in cerebral blood flow (CBF). In healthy controls (HCs), the regulation of CBF is complex and cardiac output (CO) is an important determinant of CBF: a review showed that a 30% reduction in CO results in a 10% reduction in CBF. In previous and separate ME/CFS studies, we showed that CO and CBF decreased to a similar extent during tilt testing.

View Article and Find Full Text PDF
Article Synopsis
  • The study evaluated the use of continuous video-electroencephalography (cEEG) to detect seizures in infants and children in a cardiovascular intensive care unit (CVICU), emphasizing symptoms and risk factors that led to cEEG evaluations.
  • Among 605 cEEGs performed over 38 months, seizures were found in 9% of cases, with a significantly higher detection rate (30%) when both vital sign and non-vital sign symptoms were present, while isolated vital sign changes did not yield any seizures.
  • The results indicated that certain symptoms (like gaze deviation and abnormal limb movements) and risk factors (like preexisting epilepsy and recent neuroscience surgeries) were linked to a higher likelihood of seizure detection, highlighting
View Article and Find Full Text PDF

H3K27M-mutant diffuse midline gliomas (DMGs) express high levels of the disialoganglioside GD2 (ref. ). Chimeric antigen receptor-modified T cells targeting GD2 (GD2-CART) eradicated DMGs in preclinical models.

View Article and Find Full Text PDF